Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: GSK (FKA GLAXOSMITHKLINE INC.), GSK (FKA GLAXOSMITHKLINE INC.)
Client-Reported Lobbying Expenses
$126.1M
94 filings
Summary
GSK (FKA GLAXOSMITHKLINE INC.) is an organization, based in DC. Its political footprint includes $126.1 million in client-reported lobbying expenses. Lobbying activity focuses on Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues, Trade (domestic/foreign). Political activity spans from 1999 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↑ 17% YoY
2025: $5.6M (complete years)
Activity data: Senate LDA